LDL Mid A represents a specific intermediate LDL particle subfraction that sits between the large buoyant LDL particles and the smaller more atherogenic particles. It is part of the detailed particle size distribution measured in comprehensive lipid subfraction testing.
Lipid subfraction testing maps the full spectrum of LDL particle types, from the largest and least harmful (LDL-1) through mid-range particles (LDL Mid A, B, C and LDL-2) to the most dangerous small dense LDL particles. This detailed characterisation is valuable for patients with metabolic syndrome, diabetes, or borderline cardiovascular risk where standard LDL may underestimate true risk.
FAQs
What is the clinical importance of LDL Mid A?
LDL Mid A is an intermediate subfraction with cardiovascular risk between large LDL-1 particles and the most dangerous small dense LDL particles. Its elevation contributes to total atherogenic particle burden.
Is LDL Mid A routinely tested?
No. It is part of advanced lipid subfraction analysis in specialist cardiovascular risk assessment, not standard lipid panels.
How do I improve my LDL subfraction profile?
Reducing refined carbohydrates, exercising regularly, managing weight, and adopting a Mediterranean diet all shift the LDL particle distribution toward larger, less atherogenic particles.
Does this test replace standard LDL?
No. Standard LDL remains the primary treatment target. Subfraction analysis provides additional risk stratification information, particularly when standard LDL appears borderline.
